𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis

✍ Scribed by I-Cheng Lee, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Chung-Pin Li, Pui-Ching Lee, Jen-Huey Chiang, Chien-Wei Su, Keng-Hsin Lan, Chih-Ming Yang, Jaw-Ching Wu, Han-Chieh Lin, Shou-Dong Lee

Book ID
118822610
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
238 KB
Volume
6
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of radiofrequency ablation an
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis
✍ Chia-Yang Hsu; Yi-Hsiang Huang; Yi-You Chiou; Chien-Wei Su; Han-Chieh Lin; Rheun πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 632 KB

Radiofrequency ablation (RFA) and transarterial chemoembolization (TACE) are used to treat hepatocellular carcinoma (HCC). This study was designed to compare the long-term survival of HCC patients within the Milan criteria who underwent RFA or TACE. In all, 315 RFA patients and 215 TACE patients wit

Survival benefit of patients with inoper
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injectionβ€”a single-center analysis including 132 patients
✍ H.-Peter Allgaier; Peter Deibert; Manfred Olschewski; Cornelia Spamer; Ulrich Bl πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 72 KB πŸ‘ 2 views

Hepatocellular carcinoma (HCC) is one of the most severe sequelae of chronic liver disease. The only potentially curative therapeutic options are surgical resection and orthotopic liver transplantation. In most HCC patients, however, at clinical presentation the tumors are unresectable because of mu